Home / Expertise / Life Sciences & Healthcare
side view of scientist looking into microscope in bright research lab

Life Sciences & Healthcare

Russia

With over 150 international specialist lawyers across CMS and the support of the Lifesciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the life sciences & healthcare sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Read more Read less

Feed

Show only
28 October 2019
Do­ing busi­ness in Rus­sia 2019
20 April 2020
CMS Ex­pert Guide to phar­ma­ceut­ic­al and med­ic­al device ad­vert­ising
Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
02 July 2020
Bank of Rus­sia sim­pli­fies pro­ced­ures for is­su­ing se­cur­it­ies and dis­clos­ing...
On 11 May 2020, a new Bank of Rus­sia Reg­u­la­tion* “On Stand­ards for the Is­su­ance of Se­cur­it­ies” (the “Reg­u­la­tion on Is­su­ance Stand­ards”) came in­to force. The reg­u­lat­or up­dated this Reg­u­la­tion in...
September 2019
Health­care M&A
Get­ting the Deal Through – Health­care M&A provides in­ter­na­tion­al ex­pert ana­lys­is in the main is­sues in health­care M&A trans­ac­tions. It also acts as a com­par­at­ive leg­al guide for cross bor­der or multi-jur­is­dic­tion­al activ­it­ies. Read and down­load the Rus­sia
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
26 May 2020
European Com­mis­sion must ad­dress in­tel­lec­tu­al prop­erty and AI
The Com­mit­tee on Leg­al Af­fairs (JURI) of the European Par­lia­ment has pub­lished three draft re­ports re­lat­ing to ar­ti­fi­cial in­tel­li­gence (AI). This note is about the draft re­port on in­tel­lec­tu­al prop­erty...
24/06/2019
Prices for es­sen­tial drug list medi­cines sub­ject to man­dat­ory re-re­gis­tra­tion...
On 7 June 2019, a law es­tab­lish­ing new re­quire­ments for the re-re­gis­tra­tion of prices for es­sen­tial drug list medi­cines came in­to force in Rus­sia.
22 May 2020
Rus­sia ap­proves rules for on­line sale of OTC drugs
The Rus­si­an gov­ern­ment has ap­proved the rules* for selling over-the-counter (OTC) drugs on­line. The new rules set the con­di­tions for: ob­tain­ing a per­mit to sell drugs re­motely;...
24/05/2019
CMS Rus­sia earns 33 re­cog­ni­tions by Best Law­yers 2020
CMS Rus­sia is pleased to an­nounce that all 13 firm’s part­ners and 8 coun­sel and seni­or as­so­ci­ates have been se­lec­ted for in­clu­sion in­to the 2020 edi­tion of the Best Law­yers.
22 May 2020
For­eign in­vest­ments in Ger­man life sci­ence com­pan­ies be­come sub­ject to...
In re­sponse to the COV­ID-19 pan­dem­ic, Ger­many has widened the scope of its in­vest­ment con­trol to in­clude nu­mer­ous life sci­ence com­pan­ies. The amend­ments to the For­eign Trade and Pay­ments Or­din­ance ("AWV")...
11/03/2019
Cham­bers Europe 2019: CMS con­firms its lead­ing po­s­i­tion on the Rus­si­an...
Cham­bers Europe 2019: CMS con­firms its lead­ing po­s­i­tion on the Rus­si­an leg­al mar­ket
13 May 2020
In­form­a­tion on con­trac­tu­al re­stric­tions can now be pub­lished on Fed­re­surs.ru
On 1 April 2020, amend­ments* came in­to force al­low­ing Rus­si­an leg­al en­tit­ies and in­di­vidu­al en­tre­pren­eurs to enter ad­di­tion­al in­form­a­tion about them­selves on the Fed­re­surs* web­site, as well as in­form­a­tion...